(Q35681700)

9 August 2017

1 reference

title

Impact of recent findings on study design of future autism clinical trials (English)

1 reference

9 August 2017

0 references

1

Eric Hollander

1 reference

9 August 2017

Ann Phillips

2

1 reference

9 August 2017

Bryan H King

3

1 reference

9 August 2017

Donald Guthrie

4

1 reference

9 August 2017

Michael G Aman

5

1 reference

9 August 2017

Paul Law

6

1 reference

9 August 2017

Thomas Owley

7

1 reference

9 August 2017

Ricki Robinson

8

1 reference

9 August 2017

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

9

1 reference

9 August 2017

1

1 reference

9 August 2017

49-56

1 reference

A rating scale for mania: reliability, validity and sensitivity

9 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000835X

7 January 2021

A controlled trial with ORG 2766, an ACTH-(4-9) analog, in 50 relatively able children with autism

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000835X

7 January 2021

Risperidone in children with autism and serious behavioral problems

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000835X

7 January 2021

Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000835X

7 January 2021

Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneity

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000835X

7 January 2021

Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000835X

7 January 2021

Fenfluramine treatment of twenty children with autism

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000835X

7 January 2021

Incorporating language phenotypes strengthens evidence of linkage to autism.

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000835X

7 January 2021

Secretin and autism: a two-part clinical investigation

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000835X

7 January 2021

A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000835X

7 January 2021

An open trial of divalproex sodium in autism spectrum disorders.

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000835X

7 January 2021

Multisite, double-blind, placebo-controlled trial of porcine secretin in autism

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000835X

7 January 2021

Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000835X

7 January 2021

10.1017/S109285290000835X

Identifiers

DOI

0 references

1 reference